Evidence map›Paper›PMID 31698409›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2020

Blocking CRH receptors in adults mitigates age-related memory impairments provoked by early-life adversity.

Annabel K Short, Pamela M Maras, Aidan L Pham, Autumn S Ivy, Tallie Z Baram

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Genetic variants associated with age-related episodic memory decline implicate distinct memory pathologies.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Early Adversity and Accelerated Brain Aging: A Mini-Review.Frontiers in molecular neuroscience · 2022
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Annabel K ShortDepartment of Anatomy and Neurobiology, University of California- Irvine, Irvine, CA, USA. akshort@uci.edu.ORCID http://orcid.org/0000-0001-9654-3197
Pamela M MarasMolecular and Behavioral Neuroscience Institute, University of Michigan, Ann Arbor, MI, USA.
Aidan L PhamDepartment of Anatomy and Neurobiology, University of California- Irvine, Irvine, CA, USA.
Autumn S IvyDepartment of Anatomy and Neurobiology, University of California- Irvine, Irvine, CA, USA.ORCID http://orcid.org/0000-0003-1775-6253
Tallie Z BaramDepartment of Anatomy and Neurobiology, University of California- Irvine, Irvine, CA, USA.ORCID http://orcid.org/0000-0003-0771-8616
University of California, Irvine · USUniversity of Michigan · US

Funding

Structural & Network-Function Correlates of Fragmented Early-Life Across SpeciesP50MH096889 · NIMH · UNIVERSITY OF CALIFORNIA-IRVINE · PI BARAM, TALLIE Z. · 2013 to 2023
$25.4M
Effects of Early-Life Experience: Role of CRHR01MH073136 · NIMH · UNIVERSITY OF CALIFORNIA-IRVINE · PI BARAM, TALLIE Z. · 2005 to 2020
$4.6M
CRH-MRNA REGULATION--ROLE IN NEONATAL SEIZURE POTENTIALR01NS028912 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI BARAM, TALLIE Z. · 1992 to 2014
$4.2M
NIMH NIH HHS P50 MH096889NIMH NIH HHS R01 MH073136NINDS NIH HHS R01 NS028912
6 · The paper itself

Abstract

In humans, early-life adversity is associated with impairments in learning and memory that may emerge later in life. In rodent models, early-life adversity directly impacts hippocampal neuron structure and connectivity with progressive deficits in long-term potentiation and spatial memory function. Previous work has demonstrated that augmented release and actions of the stress-activated neuropeptide, CRH, contribute to the deleterious effects of early-life adversity on hippocampal dendritic arborization, synapse number and memory-function. Early-life adversity increases hippocampal CRH expression, and blocking hippocampal CRH receptor type-1 (CRHR1) immediately following early-life adversity prevented the consequent memory and LTP defects. Here, we tested if blocking CRHR1 in young adults ameliorates early-life adversity-provoked memory deficits later in life. A weeklong course of a CRHR1 antagonist in 2-month-old male rats prevented early-life adversity-induced deficits in object recognition memory that emerged by 12 months of age. Surprisingly, whereas the intervention did not mitigate early-life adversity-induced spatial memory losses at 4 and 8 months, it restored hippocampus-dependent location memory in 12-month-old rats that experienced early-life adversity. Neither early-life adversity nor CRHR1 blockade in the adult influenced anxiety- or depression-related behaviors. Altogether, these findings suggest that cognitive deficits attributable to adversity during early-life-sensitive periods are at least partially amenable to interventions later in life.

Indexed as

Age FactorsAgingAnimalsAnimals, NewbornCRF Receptor, Type 1FemaleInjections, IntraventricularMaleMemory DisordersPregnancyPyrimidinesRandom AllocationRatsRats, Sprague-DawleyReceptors, Corticotropin-Releasing HormoneStress, PsychologicalCRF Receptor, Type 1PyrimidinesR 121919Receptors, Corticotropin-Releasing Hormone

Identifiers

PMID31698409
PMCPMC6969076
OpenAlexW2987217858

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.